GPT and pancreatic insulinoma: The fact that all findings on the poor prognostic impact of ALT are overlapping in different PanNET cohorts, including large and small lesions, G1 and G2 tumors, and non-functioning neoplasms and insulinomas, highlights that this biomarker can be used as a reliable prognostic indicator in PanNET patients.